Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: Three randomised, open-label, cross-over trials

The Lancet

Volumn 379, Issue 9816, 2012, Pages 641-647

  Johnston, Christine ^a,b   Saracino, Misty ^a   Kuntz, Steve ^a   Magaret, Amalia ^a,b   Selke, Stacy ^a   Huang, Meei Li ^a,b   Schiffer, Joshua T ^a,b   Koelle, David M ^a,b   Corey, Lawrence ^a,b   Wald, Anna ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VALACICLOVIR; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENE DOSAGE; GENITAL HERPES; HEADACHE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA; NEUTROPENIA; NUCLEOTIDE SEQUENCE; OPEN STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION; VAGINA SMEAR; VIRUS REACTIVATION; VIRUS SHEDDING;

EID: 84857233459     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61750-9     Document Type: Article

References (33)

1. KJ Looker, GP Garnett, GP Schmid An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Bull World Health Organ 86 2008 805 812
2. EE Freeman, HA Weiss, JR Glynn, PL Cross, JA Whitworth, RJ Hayes Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies AIDS 20 2006 73 83 (Pubitemid 41818117)
3. F Xu, MR Sternberg, BJ Kottiri et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 2006 964 973 (Pubitemid 44285373)
4. SR Morris, HM Bauer, MC Samuel, D Gallagher, G Bolan Neonatal herpes morbidity and mortality in California, 1995-2003 Sex Transm Dis 35 2008 14 18 (Pubitemid 351619346)
5. GJ Mertz, CC Jones, J Mills et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial JAMA 260 1988 201 206
6. M Reitano, S Tyring, W Lang et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group J Infect Dis 178 1998 603 610 (Pubitemid 28397205)
7. R Gupta, A Wald, E Krantz et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract J Infect Dis 190 2004 1374 1381 (Pubitemid 39332176)
8. A Wald, J Zeh, G Barnum, LG Davis, L Corey Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir Ann Intern Med 124 1996 8 15 (Pubitemid 26019618)
9. L Corey, A Wald, R Patel et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes N Engl J Med 350 2004 11 20 (Pubitemid 38032179)
10. C Celum, A Wald, J Hughes et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial Lancet 371 2008 2109 2119 (Pubitemid 351902179)
11. D Watson-Jones, HA Weiss, M Rusizoka et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania N Engl J Med 358 2008 1560 1571 (Pubitemid 351519816)
12. C Celum, A Wald, JR Lingappa et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 N Engl J Med 362 2010 427 439
13. K Mark, A Wald, A Magaret et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults J Infect Dis 198 2008 1141 1149
14. KE Mark, A Wald, AS Magaret et al. Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults J Acquir Immune Defic Syndr 54 2010 482 488
15. JT Schiffer, L Abu-Raddad, KE Mark et al. Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model Sci Transl Med 1 2009 7 16
16. JT Schiffer, L Abu-Raddad, KE Mark et al. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes Proc Natl Acad Sci USA 107 2010 18973 18978
17. KR Beutner, DJ Friedman, C Forszpaniak, PL Andersen, MJ Wood Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults Antimicrob Agents Chemother 39 1995 1546 1553
18. A Magaret, C Johnston, A Wald Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling Sex Transm Infect 85 2009 270 275
19. A Wald, J Zeh, S Selke et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons N Engl J Med 342 2000 844 850 (Pubitemid 30165207)
20. RL Ashley, J Militoni, F Lee, A Nahmias, L Corey Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera J Clin Microbiol 26 1988 662 667 (Pubitemid 18087189)
21. KR Jerome, ML Huang, A Wald, S Selke, L Corey Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR J Clin Microbiol 40 2002 2609 2611 (Pubitemid 34747371)
22. AS Magaret, A Wald, ML Huang, S Selke, L Corey Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa J Clin Microbiol 45 2007 1618 1620 (Pubitemid 46762423)
23. Common Terminology Criteria for Adverse Events v3.0 http://ctep.cancer. gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf (accessed Nov 13, 2011).
24. PJ Diggle, KY Liang, SL Zeger Analysis of longitudinal data 1994 Oxford University Press New York
25. JT Schiffer, A Wald, S Selke, L Corey, A Magaret The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions J Infect Dis 204 2011 554 561
26. T Czartoski, C Liu, DM Koelle, S Schmechel, A Kalus, A Wald Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman J Clin Microbiol 44 2006 1584 1586
27. F Morfin, D Thouvenot Herpes simplex virus resistance to antiviral drugs J Clin Virol 26 2003 29 37 (Pubitemid 36183346)
28. B Lebrun-Vignes, A Bouzamondo, A Dupuy, J-C Guillaume, P Lechat, O Chosidow A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks J Am Acad Dermatol 57 2007 238 246 (Pubitemid 47048864)
29. J Lycke, C Malmestrom, L Stahle Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir Antimicrob Agents Chemother 47 2003 2438 2441 (Pubitemid 36919441)
30. G Brandi, GF Schiavano, E Balestra, B Tavazzi, C-F Perno, M Magnani The potency of acyclovir can be markedly different in different cell types Life Sci 69 2001 1285 1290 (Pubitemid 32758698)
31. ZA Brown, A Wald, RA Morrow, S Selke, J Zeh, L Corey Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant JAMA 289 2003 203 209 (Pubitemid 36068708)
32. A Wald, M-L Huang, D Carrell, S Selke, L Corey Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture J Infect Dis 188 2003 1345 1351 (Pubitemid 37433705)
33. KA Workowski, S Berman Sexually transmitted diseases treatment guidelines, 2010 MMWR Recomm Rep 59 2010 1 110